دانلود رایگان مقاله تأثیر تنظیم مقادیر قیمت در زنجیره تامین دارویی – سال 2019
مشخصات مقاله:
عنوان فارسی مقاله:
تأثیر تنظیم مقادیر قیمت در زنجیره تامین دارویی
عنوان انگلیسی مقاله:
Effects of price cap regulation on the pharmaceutical supply chain
کلمات کلیدی مقاله:
زنجیره تامین دارویی، ریسک مقررات، تنظیم مقدار قیمت، قیمت گذاری
مناسب برای رشته های دانشگاهی زیر:
مدیریت – مهندسی صنایع – داروسازی
مناسب برای گرایش های دانشگاهی زیر:
مدیریت مالی – مدیریت صنعتی – لجستیک و زنجیره تامین – فارماکولوژی یا داروشناسی
وضعیت مقاله انگلیسی و ترجمه:
مقاله انگلیسی را میتوانید به صورت رایگان با فرمت PDF با کلیک بر روی دکمه آبی، دانلود نمایید. برای ثبت سفارش ترجمه نیز روی دکلمه قرمز رنگ کلیک نمایید. سفارش ترجمه نیازمند زمان بوده و ترجمه این مقاله آماده نمیباشد و پس از اتمام ترجمه، فایل ورد تایپ شده قابل دانلود خواهد بود.
فهرست مطالب:
Outline
Abstract
Keywords
۱٫ Introduction
۲٫ Literature review
۳٫ The models and equilibrium analysis
۴٫ Evaluation of price cap regulations
۵٫ Coordination of the pharmaceutical supply chain
۶٫ Conclusions and suggestions for future research
Acknowledgments
Appendix A
References
قسمتی از مقاله انگلیسی:
Abstract
This paper considers a pharmaceutical supply chain composed of one pharmaceutical manufacturer and one pharmacy. We investigate how price cap regulation affects pharmaceutical firms’ pricing decisions. We also evaluate the economic and social performance of the pharmaceutical supply chain and assess the risks associated with price cap regulation. The derived equilibriums under different price cap regulations, including retailer price cap regulation, manufacturer price cap regulation and linkage price cap regulation, are compared to that without regulation. Our results show that one-sided price cap regulation will damage the economic performance of the regulated firm, whereas the unregulated firm may gain a financial advantage. The regulation may increase the risk of a supply shortage if pharmaceutical firms cannot cope with the financial loss. In contrast, linkage price cap regulation can be an effective policy for improving both the economic and social performance of the pharmaceutical supply chain.
1. Introduction
The pharmaceutical industry plays an important role in the economy, society, and public health in almost every country in the world. The pricing of pharmaceutical products is a vital and contentious issue for both developed and developing countries (Danzon, Mulcahy, & Towse, 2015; Danzon, Towse, & Mestre-Ferrandiz, 2015). For middleand low-income countries, effective pricing of pharmaceuticals is critical to the accessibility and affordability of medicines and the population’s social welfare. For example, despite the rapid economic development in China, the high price of drugs has continuously been blamed for unaffordable healthcare service for less-advantaged people, which has triggered increasing complaints from the public (Yu, Li, Shi, & Yu, 2010). For developed countries, although the affordability of drugs may not be a challenge to their citizens due to extensive medical insurance, high drug prices have certainly increased the burden of government public expenditures
